Genflow Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:GENF.F Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
27 Mar 25	BuyUS$31,298	Eric Leire	Individual		2,100,000	US$0.015

Insider Trading Volume

Insider Buying: GENF.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GENF.F?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	6,662,500	1.7%
General Public	91,815,004	23.5%
Institutions	108,702,939	27.8%
Individual Insiders	183,867,499	47%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 74.47% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
32.4%	Eric Leire	126,514,999	US$1.5m	1.57%	no data
6.65%	Hargreaves Lansdown Asset Management Ltd.	26,019,835	US$311.1k	23.5%	no data
5.38%	Jonathan Swann	21,025,000	US$251.4k	19.6%	no data
4.47%	Adrian Beeston	17,475,000	US$209.0k	0%	no data
3.71%	Ron Bauer	14,500,000	US$173.4k	0%	no data
3.21%	Premier Fund Managers Ltd.	12,547,262	US$150.0k	-47.7%	no data
3.21%	KBC Asset Management NV	12,542,810	US$150.0k	-5.36%	no data
2.6%	Aberdeen Group Plc	10,162,638	US$121.5k	34.7%	no data
2.13%	Goy Harris Cartwright	8,317,000	US$99.5k	6.4%	0.32%
2.05%	Longevity Tech Fund A.S.	7,999,998	US$95.7k	0%	no data
1.44%	HBOS Investment Fund Managers Limited	5,618,534	US$67.2k	-28.1%	no data
1.23%	Bevilacqua PLLC	4,800,000	US$57.4k	0%	no data
0.8%	HSBC Global Asset Management (UK) Limited	3,109,250	US$37.2k	13.7%	no data
0.74%	CM-CIC Asset Management SA	2,902,076	US$34.7k	0%	no data
0.67%	Jarvis Securities plc, Asset Management Arm	2,626,253	US$31.4k	-12.2%	no data
0.64%	Eurizon Capital SGR SpA	2,496,925	US$29.9k	0%	no data
0.56%	Cantor Fitzgerald Asset Management	2,200,000	US$26.3k	0%	no data
0.38%	Newmarket Strategy Ltd	1,500,000	US$17.9k	0%	no data
0.38%	Charles Stanley & Co. Ltd, Asset Management Arm	1,478,111	US$17.7k	28.8%	no data
0.36%	TD Asset Management, Inc.	1,420,000	US$17.0k	0%	no data
0.32%	Yassine Bendiabdallah	1,270,500	US$15.2k	0%	no data
0.31%	Killik Asset Management	1,200,000	US$14.3k	0%	no data
0.3%	Peter King-Lewis	1,182,000	US$14.1k	0%	no data
0.3%	Raiffeisenlandesbank OÖ reg. GenmbH, Asset Management Arm	1,166,002	US$13.9k	0%	no data
0.29%	Barclays Bank PLC, Wealth and Investment Management Division	1,120,862	US$13.4k	-8.78%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/12 10:46
End of Day Share Price	2025/05/07 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genflow Biosciences plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.